Table 1 (A) Outlines the primary aims of the Panopia feasibility study. (B) Outlines the secondary aims of Panopia feasibility study and results.

From: Project Panopia: cost-effective model for glaucoma referral refinement from community optometrists without the need for repeat testing

A. Primary aims

Onboarding experience (n = 23)

To assess the feasibility of recruitment and retention of optometry practices

•Eighteen local practices welcomed the scheme

•Six optometric practices committed to the feasibility study and were our early adopters

•Twelve practices could not participate in the initial phase due heavy administrative burden from the newly introduced MECS scheme

•None of the practices dropped out during the course of the study

To assess the acceptability of the pathway among optometrists

•CET-accredited onboarding events were utilised to present the status quo and gather optometrists views on the intervention

•Delays into HES and high first visit discharge rates were identified as a key motivator for change by optometrists

•Additional time required to export and upload images to nhs.net email was not expressed as a concern and could be done during allocated administrative time

•The referral proforma was co-created with optometrists

To investigate pre-existing resources within the community that would facilitate the pathway

•There was a heterogeneity of equipment in all six practices

•Two of six optometric practices had OCT capabilities and a decision was made to utilise optic disc photographs instead

•Only practices with visual field machines and fundus cameras were able to participate

•Visual fields from any type of field analyser were accepted

•Although GAT was initially specified, we also accepted NCT measurements

To assess the feasibility of data transfer and interpretation

•All practices were able to export data from their VF machines and fundus cameras and upload them on to nhs.net email

•All practices utilised a bespoke referral proforma, which served as a checklist to ensure all information was provided in the referral

•Data interpretation was possible on all referrals

To evaluate financial projections for scaling up

Current scheme

Panopia scheme

Based on 853 referrals to Moorfields at Barking Glaucoma clinic in a year

Costs £

Notes

Based on 853 referrals to Moorfields at Barking Glaucoma clinic in a year

Costs £

Notes

Community Optom costs

17,913

853 referrals × £21

Community Optom costs

39,238

853 referrals × £46

Additional optometry training and equipment costs

0

 

Additional optometry training and equipment costs

0

 

HES first visit cost

150,981

853 referrals × £177

HES virtual review

102,360

853 referrals × £120 HES

Virtual tariff (68% of multiprofessional first visit cost)

HES follow-up visit cost

34,494

665 referrals (78% that would not be referred to HES if Panopia utilised) ×0.57 × £91 

1.57 extra visits prior to discharge from HES (1 New + 0.57 F/U)

£91 = F/U tariff

HES follow-up visit cost

17,108

188 referrals seen in HES ×  £91

Total

203,388

 

Total

158,706

 

Cost saving for 853 patients £203,388–158,706 = £44,682

Cost saving per patient £44,682/853 = £52

NB: 1.57 visits prior to discharge is for all ophthalmology outpatients and is taken from the Manchester glaucoma Enhanced referral scheme [14]

NB: If we calculate costs based on 1.0 visits prior to discharge, rather than 1.57 visits per discharge, the scheme still makes a saving of £12 per patient

The figure for HES virtual review quoted as £120 represents 68% of an F2F first visit appointment and is a baseline figure suggested on the NHSE/I tariff release for 2019;, this figure would need to be agreed at a local level and in the context of any local arrangements such as block contracting to ensure that providers are appropriately remunerated for this high volume work. This still allows a saving at the CCG level while ensuring any reduction in ‘new F2F activity’ in a HES setting does not impact negatively on the secondary care providers

We anticipate that reduced F2F activity would allow improved RTT and access to service, meaning that HES would never be below its functional capacity

B. Secondary aims

To assess whether remote decisions can be made on new glaucoma referrals with a complete dataset from referring optometrists

Remote decisions could be made on all referrals.

Provisional diagnosis, n = 23

Referral outcome, n = 23

Referral to HES, n = 5

Glaucoma suspect (suspicious disc, normal IOP, normal VF) 43% (10)

Discharge 26% (6)

Referral time frame::urgent (<2 weeks)/soon (2–4 weeks)/routine (<12 weeks)

Narrow angles 17% (4)

Annual review with optom 35% (8)

 

Primary open-angle glaucoma 13% (3)

(annual review with optom 17% (4)—narrow angles)

Urgent: 4% (1 pt.)

Normal tension glaucoma 4% (1)

HES review 22% (5)

Soon: 17% (4 pts)

Primary angle closure 4% (1)

 

Routine: 0% (0 pts)

Ocular hypertension 4% (1)

  

Non-glaucomatous disc 4% (1)

  

No abnormality detected 9% (2)

  

To set up a Learning Network and embed learning into the pathway, to facilitate upskilling of optometrists

•Onboarding events included practical skills training for GAT, VH, disc assessment

•All optometrists received referral advice and feedback within 5 days

•One to two referrals were chosen monthly as an educational case/s with annotated disc images and VF communicated via email to all optometrists

  1. MECS minor eye conditions, CET continuing education and training, HES hospital eye service, OCT optical coherence tomography, GAT Goldmann applanation tonometry, VF visual field, VH Van Herick limbal chamber depth, IOP intraocular pressure, CCG Clinical commissioning group, F2F face to face, RTT referral to treatment